Skip to main content

Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels

The stock market rout pushed down shares of biotechnology companies by as much as 20%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.